Source: Clinical Trials Arena

Teon: Teon treats first subject in Phase I/II solid tumour therapy trial

In the trial, the company plans to enrol 200 subjects with advanced solid tumours. The post Teon treats first subject in Phase I/II solid tumour therapy trial appeared first on Clinical Trials Arena.

Read full article »

Teon's Competitors | Teon's News | Teon's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

CEO

Serge Messerlian

CEO Approval Rating

90/100

Teon Therapeutics is a California-based biopharmaceutical company that develops and commercializes small molecule therapeutics for the treatment of cancer.